Boothbay Fund Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $823K | Buy |
+4,770
| New | +$823K | 0.02% | 583 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1675 |
|
|
2021
Q3 | – | Sell |
-2,745
| Closed | -$361K | – | 1649 |
|
|
2021
Q2 | $361K | Sell |
2,745
-5,063
| -65% | -$666K | 0.01% | 1025 |
|
|
2021
Q1 | $1.01M | Sell |
7,808
-3,144
| -29% | -$405K | 0.04% | 474 |
|
|
2020
Q4 | $1.83M | Buy |
+10,952
| New | +$1.83M | 0.07% | 235 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 908 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 829 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 748 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 745 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 671 |
|
|
2019
Q2 | – | Sell |
-23,167
| Closed | -$2.73M | – | 632 |
|
|
2019
Q1 | $2.73M | Buy |
+23,167
| New | +$2.73M | 0.26% | 59 |
|